Syngene and the Indian Institute of Science (IISc) hosted a grant submission workshop at the IISc’s huge Bangalore campus. The purpose was to have a free exchange of ideas and to learn about the research expertise and infrastructure of the faculties. The occasion was attended by Syngene researchers, senior leaders, and IISc faculty members.
“These events will help us gain insights into cutting-edge research activities in IISc and similar organizations and allow further collaboration and insightful problem-solving in different areas,” Speaking about the event, our COO, Dr. Mahesh Bhalgat said.
Around 20 research concepts were given by IISc scientists. Fighting COVID-19 by developing antivirals based on an anti-sense oligo combination against a wide range of SARS-CoV-2 variants and designing an antigen presentation cell-targeting approach to improving vaccine efficiency were among the issues discussed. The development of innovative therapies to suppress vascular endothelial growth factor, which promotes cancer metastasis and age-related macular degeneration, was also mentioned as a way to combat serious diseases.
The discussions also included the use of an ELISA-based biological technique to identify somatostatin hormone release in the early diagnosis of diabetes-related diseases. Other topics discussed during the session included performance evaluation of chemotherapeutic drugs and drug carriers using a paper-based tumour tissue model, methods to induce bone regeneration using ultrasound-mediated stem cell differentiation, and training of a machine learning model (XG Boost) to identify crystal polymorphs of Acetaminophen.
We propose to sponsor a few research initiatives at IISc as part of Syngene’s Corporate Social Responsibility (CSR) effort. These contacts provide a fantastic opportunity to establish a scientific network with prestigious universities and bridge the gap between industry and academia.
Contact us with your feedback and suggestions.